Enveric Biosciences, Inc. (ENVB) vs Alaunos Therapeutics, Inc. (TCRT)
- Enveric Biosciences, Inc. ENVB 1.38 −0.72%
- Alaunos Therapeutics, Inc. TCRT 2.63 +20.64%
Enveric Biosciences, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Alaunos Therapeutics, Inc. are of similar size ($6.4M and $6.2M). Enveric Biosciences, Inc. grew revenue faster over the last twelve months: −13.9% against −17.7%. Across the 13 metrics below, Enveric Biosciences, Inc. leads on 7 and Alaunos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ENVB | TCRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (185.95%) | (56.36%) |
| Return on assets | (193.53%) | (128.30%) | (48.04%) |
| Return on invested capital | 0.00% | (480.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack